Revenue segments as reported by the company.

Net revenue, before excise taxes

Excise taxes

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Sales and marketing

Research and development

General and administrative

Restructuring costs

Share-based payments

Depreciation and amortization

Impairment loss on goodwill and indefinite-lived intangible assets

Impairment loss on long-lived assets

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Cronos Group

Cronos Group, Inc. engages in the production and distribution of cannabis. Its brands include PEACE NATURALS, COVE, Spinach, Lord Jones, and PEACE+. The company was founded by Lorne Michael Gertner and Paul Rosen on August 21, 2012 and is headquartered in Toronto, Canada.

Earnings data Q4 2020

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Cronos Group, Inc. engages in the production and distribution of cannabis. I It operates through the Canada and Israel segments. The company was founded on August 21, 2012 and is headquartered in Toronto, Canada.

Curaleaf Holdings, Inc.

SNDL Inc.

Cannabis stocks have navigated an extended period of uncertainty and financial depression thanks to regulatory headwinds. Further, most cannabis companies have witnessed an extended period of cash burn.

Hidden Gems: 3 Cannabis Stocks Flying Under the Radar

OrganiGram Holdings Inc.

Marijuana stock investors are keeping focused on the future of the cannabis industry. Right now even with an increase in volatile trading, the industry is still progressing. There are more states and global regions that are working to establish legal cannabis markets. It seems that the toughest hurdle to get passed is cannabis reform whether it's the state level or federal. Although federal reform is what some are calling the last true obstacle of the sector. Now for the US cannabis industry, this holds more truth than not.

Best Cannabis & Marijuana Stocks For Q3 2023

Bitfarms Ltd

Polestar Automotive Holding UK PLC

The market year-to-date has been rewarding after the big correction witnessed last year. There are several growth and penny stocks that have bounced back strongly after being decimated last year.

3 Penny Stocks That Can Still Double Before the End of 2023

Bausch Health Companies Inc

Canopy Growth

GrowGeneration Corp

Green Thumb Industries Inc.

Jazz Pharmaceuticals

Scotts Miracle-Gro

There's a reason people are looking for cannabis stocks to buy now. It is increasingly likely that marijuana will be rescheduled from a Schedule I controlled substance to a Schedule III controlled substance.

7 Cannabis Stocks to Buy BEFORE the Marijuana Rescheduling Boom

AdvisorShares Pure US Cannabis ETF

The U.S.-listed shares of Cronos Group Inc. CRON, -3.24% CRON, -3.56% climbed 2.5% in premarket trading Monday, after the Toronto-based cannabis company said it launched its Peace Naturals medical brand in Germany. The company has signed a distribution agreement with Cansativa Group, which has a network of about 2,000 pharmacies in Germany.

Cronos stock climbs after launching Peace Naturals medical cannabis brand in Germany

TORONTO, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) announced today that it shipped its first order of bulk cannabis, which will be sold under the PEACE NATURALS® brand in Germany. In July, Cronos signed a distribution agreement with Cansativa Group (“Cansativa”), one of the leading distributors of medical cannabis in Germany. Cansativa is a market leader in the medical cannabis market and is a driving force in the German cannabis industry. Cansativa has a network of approximately 2,000 pharmacies domestically; they currently supply around 300,000 patients in Germany's medical market.

Cronos launches leading medical brand PEACE NATURALS® in Germany

Borr Drilling Ltd

ChargePoint Holdings

EHang Holdings Ltd - ADR

Piedmont Lithium

Riot Blockchain

Solid Power

I believe that it's a good time to accumulate some undervalued small-cap stocks. The S&P 500 index should have a sustained rally next year.

The 7 Most Undervalued Small-Cap Stocks to Buy in September 2023

The House of Representatives is set to meet to discuss several pot-related measures this week. The march toward full U.S. legalization continues to gather pace.

Why Marijuana Stocks Triumphed on Monday

Tilray Brands

Marijuana penny stocks and higher-priced cannabis stocks are having a moment in the stock market right now. Mainstream stock market news is about inflation being high, and considered a negative.

Marijuana Penny Stocks Are On Fire, 3 To Watch Right Now

The global buzz around medical cannabis stocks just got a whole lot louder. The corridors of the U.S. health sector are abuzz with the federal Health and Human Services Department urging the government to re-evaluate its hard stance on marijuana effectively.

3 Medical Cannabis Stocks Poised for Global Growth

Aurora Cannabis

Easterly Government Properties

Harte Hanks

Philip Morris

Constellation Brands

Stocks that deal in cannabis are rising as the U.S. government moves toward re-classifying marijuana. The Department of Health and Human Services (HHS) has asked the Drug Enforcement Administration (DEA) to consider moving marijuana from Schedule I to Schedule III.

Why Are Cannabis Stocks Still Up Today?

Innovative Industrial Properties

Chicago Atlantic Real Estate Finance

Curaleaf Holdings Inc. OTCMKTS: CURLF,  Innovative Industrial Properties Inc. NYSE: IIPR and Tilray Inc. NASDAQ: TLRY were among cannabis stocks jumping higher after the Department of Health and Human Services recommended that marijuana no longer be classified as a Schedule 1 drug.

Will This New Development Mean A Big Rally In Cannabis Stocks?

Cannabis stocks have come roaring back on recent news of major decriminalization progress at the federal level. The big question now for anyone who owns marijuana stocks or is considering the sector: Is there more upside left?

Cannabis stocks are still a buy despite recent double-digit gains

Trulieve Cannabis Corp.

Cannabis stocks continued to move higher following the Labor Day long weekend after the U.S. Department of Health and Human Services (HHS) last week recommended reclassifying marijuana as a lower-risk drug.

Cannabis stock rally continues on marijuana rescheduling hopes

The cannabis industry is still evolving and has had its fair share of ups and downs. There has been an ongoing battle to establish better laws and regulations. Right now many legal states are facing concerns of high state taxes and other regulatory concerns. This has made it tough not just to invest but also to see sustainable market momentum. Still, there is a lot to look forward to as overall progress continues for the industry.

3 Marijuana Stocks To Buy In September?

De facto U.S. marijuana legalization on the Federal level could be coming sooner than many think. A top official at the Department of Health and Human Services has requested that pot be rescheduled as a far less dangerous drug.

Why Investors Were so High on Cronos Stock This Week

Cannabis stocks are on track to finish the week higher boosted by the news that the U.S. Department of Health and Human Services (HHS) has recommended reclassifying marijuana as a lower-risk drug.

Cannabis stocks set to end week on a high following marijuana rescheduling recommendation

Canopy Growth (CGC), Tilray (TLRY) and Cronos (CRON) shoot up on news that the DEA is considering recommendations for low-risk reclassification of marijuana.

3 Cannabis Stocks Soaring on HHS' Recommendation to DEA

Cannabis stocks are celebrating this morning after the U.S. Department of Health and Human Services recommended in a letter to the Drug Enforcement Administration that Marijuana be reclassified as a Schedule III drug.

Why are cannabis stocks trading significantly up on Thursday?

Shares of marijuana companies climbed as much as 14% in morning trading on Thursday after the Department of Health and Human Services recommended its reclassification as a lower-risk substance following an 11-month review.

Pot firms gain as US move to ease curbs boosts sentiment

The U.S. government appears finally to be ready to review its categorization of marijuana as a dangerous drug, reviving hope among investors and marijuana producers for an industry that took off like a rocket five years ago before sinking like a rock less than two years later.

Will a Change to US Marijuana Policy Save Any of the Weed Companies?

The continued lack of legalization of marijuana at the federal level is preventing greater growth across the industry. That could change by the end of this year.

3 Cannabis Stocks Poised for Blazing-Hot Growth in 2024

Assistant Secretary for Health Rachel Levine reportedly requested in a letter to DEA Administrator Anne Milgram that marijuana be downgraded to a schedule III substance.

Pot stocks rally after health officials ask DEA to reclassify marijuana as lower-risk drug

Roundhill Cannabis ETF

The Drug Enforcement Agency received an official recommendation to downgrade marijuana.  Currently, pot is classified as a Schedule I drug, on par with heroin.

Pot stocks jump as federal agency reportedly seeks to downgrade cannabis from the hard-drug category

That move could potentially expand the market for cannabis, sending shares of Canopy Growth, Tilray Brands and Cronos Group higher.

HHS calls for easing restrictions on marijuana, sending cannabis stocks higher

News for Cronos Group Stock (CRON)